Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
78.25    0.30 (0.38%)
Bid:
77.85
Ask:
78.45
Spread: 0.60 (0.771%)
Market Cap: £1.50b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Trading Statement

21 May 2025 07:00

RNS Number : 4823J
Coats Group PLC
21 May 2025
 

21 May 2025

Coats Group plc

Trading Update

 

Continued trading momentum - full-year outlook in line with expectations

 

Coats Group plc ('Coats', the 'Company' or the 'Group'), the world's leading industrial thread and global footwear component manufacturer, today announces a trading update for the four month period from 1 January to 30 April 2025 (the 'period') ahead of its Annual General Meeting to be held later today.

 

1 January to 30 April 2025 revenues vs same period in 2024

CER2

Reported

Apparel

5%

3%

Footwear

5%

4%

Performance Materials1

0%

-3%

Group1

4%

2%

 

1 Excluding US Yarns business

2 Constant exchange rate (CER) figures are 2024 results restated at 2025 exchange rates

 

All following references are at CER unless specified.

 

The Group delivered a good performance in the period with revenue up 4%, reflecting continued momentum in Apparel and Footwear which both achieved 5% year-on-year growth, building further on the recovery seen in 2024. Performance Materials traded in line with expectations, with revenue excluding US Yarns at a similar level to the same period last year, as subdued conditions continue to affect a number of key end markets.

 

In line with our medium-term financial framework, underlying Group EBIT margins continued to improve, with further efficiency gains funding investment in our growth drivers.

 

Following the closure of our plant in Toluca, Mexico in Q4 2024, we announced in April 2025 our intention to fully exit from the low-margin US Yarns business based in Kings Mountain, North Carolina. Earlier this month, we agreed to sell the business and assets of US Yarns, and this will generate net cash proceeds of around $16m, with completion expected in June 2025. The US Yarns business had sales of $68m and EBIT of $3m in 2024, and this exit will further improve the quality of the Coats portfolio as well as margins.

 

Outlook

 

Given the positive start to the year and our current order book visibility, we expect the first half performance to reflect an adjusted EBIT margin within our medium-term margin target range of 19-21%.

 

The recently announced US-led trade tariffs have created elevated uncertainty in a number of markets and we continue to monitor this situation closely. This remains a dynamic backdrop and consequently challenging at this point to determine any indirect impact on future demand, but we have been encouraged by the continued positive momentum through the period. The Group is a global market leader with a proven and resilient business model - with a global footprint, low capital intensity, a flexible cost base and proven pricing power - which continues to position us strongly to navigate any market volatility.

 

Whilst mindful of the dynamic backdrop, our full year expectations remain unchanged, with a broadly equal profit weighting across H1 and H2. We expect another year of strong free cash flow generation, supporting the Group's active and flexible capital allocation strategy. We continue to build a pipeline of attractive acquisition targets to further strengthen our portfolio, with the capacity to take advantage of any opportunities created by any disruption.

 

Commenting on the results David Paja, Group Chief Executive, said:

 

"We have traded well in the first few months of 2025 and we expect to finish the first half with performance ahead of the prior year, reflecting both growth and further margin expansion.

 

It is too early to be definitive on any longer-term impact from tariffs and trade restrictions but I am confident in the Group's ability to navigate different scenarios with a well-honed playbook, while continuing to invest in our growth initiatives. Our client relationships, global footprint and high-quality product portfolio will underpin the delivery of market leading growth and profitability, together with substantial and increasing free cash flow."

 

The Group will release its 2025 Interim Results on 31 July 2025.

 

Enquiry details

Investors

Anjali Kotak

Coats Group plc

+44 (0) 7880 471 350

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0) 20 3727 1374

 

 

About Coats Group plc

Coats is a world leader in thread manufacturing and structural components for apparel and footwear, as well as an innovative pioneer in performance materials. These critical solutions are used to create a wide range of products, including ones that provide safety and protection for people, data and the environment. Headquartered in the UK, Coats is a FTSE250 company and a FTSE4Good Index constituent. Revenue in 2024 was $1.5 billion.

Trusted by the world's leading companies to deliver crucial, innovative, and sustainable solutions, Coats provides value-adding products including apparel, accessory and footwear threads, structural footwear components, fabrics, yarns and software applications. Customer partners include companies from the apparel, footwear, automotive, telecoms, personal protection, and outdoor goods industries.

 

With a proud heritage dating back more than 250 years and a spirit of evolution to constantly stay ahead of changing market needs, Coats has operations across some 50 countries with a permanent workforce of more than 16,000, serving its customers worldwide.

 

Coats connects talent, textiles, and technology, to make a better and more sustainable world. Worldwide, there are four dedicated Coats Innovation Hubs, where experts collaborate with partners to create the materials and products of tomorrow. It participates in the UN Global Compact and is committed to validated Science Based sustainability targets for 2030 and beyond, with an aspiration of achieving net-zero by 2050. Coats is also committed to achieving

its goals in Diversity, Equity & Inclusion, workplace health & safety, employee & community wellbeing, and supplier social performance. To find out more about Coats visit www.coats.com.

 

Cautionary statement

Certain statements in this trading update are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, we can give no assurance that these expectations will prove to have been correct. Because these statements contain risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKKBQABKDPPB
Date   Source Headline
25th Sep 20232:56 pmRNSHolding(s) in Company
14th Sep 202311:47 amRNSHolding(s) in Company
1st Sep 20237:00 amRNSDeal Completion
4th Aug 202311:54 amRNSDirector/PDMR Shareholding
4th Aug 202311:48 amRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSDivestment of European Zips
6th Jun 20239:00 amRNSAppointment of Joint Corporate Broker
22nd May 202310:28 amRNSDirector Declaration
17th May 20234:23 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
12th Apr 202312:47 pmRNSBlock listing Interim Review
27th Mar 20234:15 pmRNSHolding(s) in Company
22nd Mar 202312:39 pmRNSHolding(s) in Company
20th Mar 20232:41 pmRNSDirector/PDMR Shareholding
20th Mar 20232:40 pmRNSDirector/PDMR Shareholding
17th Mar 20234:44 pmRNSDirectorate Change
14th Mar 202312:38 pmRNSHolding(s) in Company
14th Mar 202312:25 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSDirector/PDMR Shareholding
9th Mar 202311:23 amRNSAnnual Financial Report
3rd Mar 202312:20 pmRNSDirector/PDMR Shareholding
3rd Mar 202312:17 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNS2022 Full Year Results
23rd Feb 202310:31 amRNSHolding(s) in Company
20th Feb 20237:00 amRNS$250m US private placement
16th Feb 20239:19 amRNSHolding(s) in Company
9th Dec 20229:23 amRNSHolding(s) in Company
6th Dec 20227:00 amRNSUK pension scheme update
23rd Nov 20227:00 amRNSTrading Statement
11th Nov 202211:01 amRNSHolding(s) in Company
11th Nov 20227:00 amRNSChange of Auditor
4th Nov 20227:00 amRNSDirectorate Change
19th Oct 20222:57 pmRNSHolding(s) in Company
11th Oct 20227:00 amRNSCapital Markets Day
5th Oct 20221:19 pmRNSBlock listing Interim Review
5th Oct 20221:10 pmRNSHolding(s) in Company
7th Sep 20221:52 pmRNSHolding(s) in Company
31st Aug 20222:17 pmRNSDirector/PDMR Shareholding
31st Aug 20221:39 pmRNSTotal Voting Rights
25th Aug 202210:40 amRNSHolding(s) in Company
25th Aug 20227:00 amRNSDirectorate Change
24th Aug 20228:55 amRNSHolding(s) in Company
23rd Aug 20223:23 pmRNSDeal completion
16th Aug 20229:47 amRNSHolding(s) in Company
15th Aug 20229:53 amRNSDirector/PDMR Shareholding
12th Aug 20222:55 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSResults of Capital Raise
10th Aug 20224:37 pmRNSREX Retail Offer
10th Aug 20224:36 pmRNSProposed Capital Raise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.